brigatinib
ItalyDrugs containing this active substance
-
It is used for the treatment of adults with advanced non-small cell lung cancer whose tumor is associated with an abnormal form of the ALK gene.
Form: tablets, film-coated
Active substance Dosage brigatinib - ATC: L01ED04
Manufacturer: TAKEDA PHARMA A/S